Inrebic Uni Eropa - Norwegia - EMA (European Medicines Agency)

inrebic

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiske midler - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Buprefarm 30 mikrog/ time Norwegia - Norwegia - Statens legemiddelverk

buprefarm 30 mikrog/ time

orifarm generics a/s - buprenorfin - depotplaster - 30 mikrog/ time

Bugnanto 5 mikrog/ time Norwegia - Norwegia - Statens legemiddelverk

bugnanto 5 mikrog/ time

sandoz - københavn - buprenorfin - depotplaster - 5 mikrog/ time

Bugnanto 10 mikrog/ time Norwegia - Norwegia - Statens legemiddelverk

bugnanto 10 mikrog/ time

sandoz - københavn - buprenorfin - depotplaster - 10 mikrog/ time

Bugnanto 20 mikrog/ time Norwegia - Norwegia - Statens legemiddelverk

bugnanto 20 mikrog/ time

sandoz - københavn - buprenorfin - depotplaster - 20 mikrog/ time

Livtencity Uni Eropa - Norwegia - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.

Bugnanto 30 mikrog/ time Norwegia - Norwegia - Statens legemiddelverk

bugnanto 30 mikrog/ time

sandoz - københavn - buprenorfin - depotplaster - 30 mikrog/ time

Cinacalcet STADA 30 mg Norwegia - Norwegia - Statens legemiddelverk

cinacalcet stada 30 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 30 mg

Cinacalcet STADA 60 mg Norwegia - Norwegia - Statens legemiddelverk

cinacalcet stada 60 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 60 mg

Cinacalcet STADA 90 mg Norwegia - Norwegia - Statens legemiddelverk

cinacalcet stada 90 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 90 mg